EDITORIAL
Published on 15 Feb 2022
Editorial: Cancer Therapeutics: Targeting DNA Repair Pathways
doi 10.3389/fmolb.2022.858514
- 1,238 views
- 3 citations
- Frontiers in Molecular Biosciences
- Molecular Diagnostics and Therapeutics
- Research Topics
- Cancer Therapeutics: Targeting DNA Repair Pathways
Cancer Therapeutics: Targeting DNA Repair Pathways
16k
Total downloads
65k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
BRIEF RESEARCH REPORT
Published on 11 Jan 2022
Pharmacological Targeting of STING-Dependent IL-6 Production in Cancer Cells
doi 10.3389/fcell.2021.709618
- 4,077 views
- 14 citations
REVIEW
Published on 07 Jul 2021
Epigenetic Mechanisms in DNA Double Strand Break Repair: A Clinical Review
doi 10.3389/fmolb.2021.685440
- 9,186 views
- 28 citations
ORIGINAL RESEARCH
Published on 10 Jun 2021
MCM4 Is a Novel Biomarker Associated With Genomic Instability, BRCAness Phenotype, and Therapeutic Potentials in Soft-Tissue Sarcoma
doi 10.3389/fcell.2021.666376
- 2,464 views
- 6 citations
BRIEF RESEARCH REPORT
Published on 29 Apr 2021
Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma
doi 10.3389/fmolb.2021.633344
- 3,656 views
- 11 citations
REVIEW
Published on 23 Mar 2021
Cell Metabolism and DNA Repair Pathways: Implications for Cancer Therapy
doi 10.3389/fcell.2021.633305
- 12,536 views
- 46 citations
ORIGINAL RESEARCH
Published on 11 Mar 2021
Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate Cancer
doi 10.3389/fmolb.2021.608369
- 3,038 views
- 14 citations
REVIEW
Published on 13 Jan 2021
Regulator of Chromosome Condensation 2 Modulates Cell Cycle Progression, Tumorigenesis, and Therapeutic Resistance
doi 10.3389/fmolb.2020.620973
- 3,758 views
- 13 citations
ORIGINAL RESEARCH
Published on 10 Dec 2020
Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma
doi 10.3389/fmolb.2020.604766
- 3,961 views
- 46 citations
ORIGINAL RESEARCH
Published on 23 Oct 2020
PAXX, Not NHEJ1 Is an Independent Prognosticator in Colon Cancer
doi 10.3389/fmolb.2020.584053
- 4,570 views
- 14 citations
REVIEW
Published on 15 Sep 2020
The Multifaceted Roles of RCC1 in Tumorigenesis
doi 10.3389/fmolb.2020.00225
- 9,454 views
- 31 citations
Published in
Frontiers in Molecular Biosciences
- Molecular Diagnostics and Therapeutics
- Cellular Biochemistry
Participating Journals
Frontiers in Cell and Developmental Biology
- 4.6 impact factor
- 9.7 citescore
Impact
- 65kTopic views
- 47kArticle views
- 16kArticle downloads